V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212210 | 20078884 | 1.65 | 51.3 | Neo-adjuvant (N) | 2019-12-18 | 2019-12-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101154535 |
| 20212211 | 20078885 | 1.56 | 66.7 | Curative (C) | 2019-06-19 | 2019-06-21 | CISPLATIN + FLUOROURACIL + RT | N | N | CISPLATIN + FLUOROURACIL | 101696089 |
| 20212212 | 20078886 | 1.83 | 118.8 | Neo-adjuvant (N) | 2019-08-04 | 2019-08-31 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100643057 |
| 20212213 | 20078887 | 1.57 | 54.8 | Palliative (P) | 2019-12-22 | 2020-01-05 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100376480 |
| 20212214 | 20078888 | 1.57 | 71.2 | Neo-adjuvant (N) | 2016-09-18 | 2016-10-03 | CAPECITABINE + CARBOPLATIN | null | N | TRIAL UNSPECIFIED | 101175547 |
| 20212215 | 20078889 | 1.69 | 80 | null | 2017-09-15 | 2017-09-24 | Cisplatin +Fluorouracil (3 wk) | 2 | null | CISPLATIN + FLUOROURACIL | 100557966 |
| 20212216 | 20078890 | 1.69 | 50.9 | Neo-adjuvant (N) | 2020-01-14 | 2020-01-27 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101632812 |
| 20212218 | 20078891 | 1.53 | 97 | Adjuvant (A) | 2016-06-23 | 2016-07-04 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100013972 |
| 20212219 | 20078892 | 0 | 0 | Curative (C) | 2019-07-30 | 2019-08-27 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100773491 |
| 20212220 | 20078893 | 0 | 0 | Neo-adjuvant (N) | 2018-03-08 | 2018-03-23 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101655483 |
| 20212221 | 20078894 | 1.85 | 42 | 03 | 2018-08-05 | 2018-09-04 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101529631 |
| 20212222 | 20078895 | 1.77 | 63.8 | Curative (C) | 2016-05-29 | 2016-06-06 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100338107 |
| 20212223 | 20078896 | 1.62 | 73.1 | null | 2018-09-25 | 2018-09-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101586305 |
| 20212224 | 20078897 | 1.74 | 83.9 | Neo-adjuvant (N) | 2017-08-15 | 2017-08-15 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 100176857 |
| 20212225 | 20078898 | 1.69 | 74.2 | Curative (C) | 2017-09-27 | 2017-09-28 | Trial Unspecified | 02 | Y | TRIAL UNSPECIFIED | 101326413 |
| 20212226 | 20078899 | 1.61 | 71 | Neo-adjuvant (N) | 2017-02-09 | 2017-02-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100221503 |
| 20212227 | 20078900 | 1.7 | 72.45 | Palliative (P) | 2016-12-14 | 2016-12-23 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100809589 |
| 20212228 | 20078901 | 1.72 | 43 | Neo-adjuvant (N) | 2019-10-24 | 2019-10-24 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101372162 |
| 20212229 | 20078902 | 1.79 | 71.55 | Neo-adjuvant (N) | 2018-03-13 | 2018-03-16 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101306598 |
| 20212230 | 20078903 | 1.52 | 44 | Neo-adjuvant (N) | 2016-07-22 | 2016-08-14 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100313822 |
| 20212231 | 20078904 | 1.65 | 81.3 | null | 2018-03-17 | 2018-03-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100094119 |
| 20212232 | 20078905 | 1.8 | 79 | Palliative (P) | 2019-09-01 | 2019-09-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100683263 |
| 20212233 | 20078906 | 1.7 | 57.9 | Curative (C) | 2019-06-27 | 2019-07-03 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101549999 |
| 20212234 | 20078907 | null | 67 | Curative (C) | 2017-02-17 | 2017-02-27 | CAPECITABINE + CARBOPLATIN | 02 | Y | DOXORUBICIN EMBOLISATION | 101012465 |
| 20212237 | 20078908 | 1.77 | 38.8 | Palliative (P) | 2019-07-29 | 2019-08-18 | Capecitabine (21days) + Carboplatin | N | N | CISPLATIN + FLUOROURACIL | 101733458 |
| 20212238 | 20078909 | 1.59 | 69.8 | 03 | 2016-12-04 | 2016-12-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100358011 |
| 20212239 | 20078910 | 1.52 | 97.2 | Curative (C) | 2019-10-14 | 2019-10-15 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100161049 |
| 20212240 | 20078911 | 1.8 | 80 | Neo-adjuvant (N) | 2019-09-01 | 2019-09-08 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101586185 |
| 20212241 | 20078912 | 1.43 | 58.8 | 02 | 2018-07-08 | 2018-07-18 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100035987 |
| 20212242 | 20078913 | 1.52 | 68.2 | 03 | 2018-11-02 | 2018-12-03 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101149235 |
| 20212243 | 20078914 | 1.78 | 71.1 | 03 | 2017-04-27 | 2017-05-04 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101257014 |
| 20212244 | 20078915 | 1.66 | 54 | Curative (C) | 2016-07-19 | 2016-08-07 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100948701 |
| 20212245 | 20078916 | 1.68 | 58 | 03 | 2019-07-08 | 2019-07-11 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101038841 |
| 20212246 | 20078917 | 1.64 | 0 | Curative (C) | 2019-05-20 | 2019-05-27 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 101227608 |
| 20212247 | 20078918 | 1.66 | 47 | null | 2018-11-29 | 2018-12-13 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 100636341 |
| 20212248 | 20078919 | 1.76 | 64 | Neo-adjuvant (N) | 2019-09-10 | 2019-09-16 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101302826 |
| 20212249 | 20078920 | null | null | null | 2017-07-26 | 2017-08-23 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101531299 |
| 20212251 | 20078921 | 1.66 | 50.8 | Curative (C) | 2018-09-06 | 2018-09-09 | Capecitabine (21days) + Carboplatin | 02 | Y | CISPLATIN + FLUOROURACIL | 101213979 |
| 20212253 | 20078922 | 0 | 0 | Palliative (P) | null | 2018-05-31 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100492310 |
| 20212254 | 20078923 | null | null | Curative (C) | null | 2018-08-18 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101773540 |
| 20212256 | 20078924 | null | 81.8 | null | 2019-01-04 | 2019-01-04 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100573885 |
| 20212257 | 20078925 | 1.59 | 84 | Neo-adjuvant (N) | 2019-11-05 | 2019-12-04 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 100092045 |
| 20212258 | 20078926 | 1.57 | 75.6 | null | 2018-04-14 | 2018-05-05 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101670376 |
| 20212260 | 20078927 | 1.6 | 83 | Curative (C) | 2021-06-07 | 2021-06-16 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100268445 |
| 20212261 | 20078928 | 1.74 | 99.9 | Palliative (P) | 2018-06-06 | 2018-06-26 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100465631 |
| 20212262 | 20078929 | null | 79.75 | Curative (C) | 2017-08-03 | 2017-08-17 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100124589 |
| 20212264 | 20078930 | 1.59 | 72 | Palliative (P) | 2019-08-21 | 2019-08-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100146061 |
| 20212265 | 20078931 | 1.67 | 0 | Curative (C) | 2018-06-05 | 2018-06-12 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101779282 |
| 20212266 | 20078932 | 1.6 | 41.4 | Neo-adjuvant (N) | 2018-03-13 | 2018-03-13 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100915023 |
| 20212268 | 20078933 | 1.6 | 65 | Neo-adjuvant (N) | 2016-06-13 | 2016-06-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100335970 |